6451-86-1

Basic information

• Product Name: 2-Bromo-4-methoxy-5-(benzyloxy)benzaldehyde
• Synonyms: 2-BROMO-4-METHOXY-5-(BENZYLOXY)BENZALDEHYDE;6-BROMOBENZYL ISOVANILLIN;5-BENZYLOXY-2-BROMO-4-METHOXY-BENZALDEHYDE;5-Benzyl-2-bromo-4-methoxylbenzaldehyde;2-Bromo-4-methoxy-5-;Benzaldehyde,2-broMo-4-Methoxy-5-(;2-broMo-4-Methoxy-benzyloxybenzaldehyde
• CAS NO: 6451-86-1
• Molecular Formula: C₁₅H₁₃BrO₃
• Molecular Weight: 321.17
• Product Categories: Fluorobenzene;Multisubstituted Benzene;Aromatic Aldehydes & Derivatives (substituted)
• Mol File: 6451-86-1.mol
• Article Data: 28

Chemical Properties

• Melting Point: 142.4-143.3 °C(Solv: hexane (110-54-3); ethyl acetate (141-78-6))
• Boiling Point: 427.5 °C at 760 mmHg
• Flash Point: 212.3 °C
• Appearance: /
• Density: 1.421 g/cm³
• Vapor Pressure: 1.63E-07mmHg at 25°C
• Refractive Index: 1.611
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• CAS DataBase Reference: 2-Bromo-4-methoxy-5-(benzyloxy)benzaldehyde(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Bromo-4-methoxy-5-(benzyloxy)benzaldehyde(6451-86-1)
• EPA Substance Registry System: 2-Bromo-4-methoxy-5-(benzyloxy)benzaldehyde(6451-86-1)

Safety Data

• Hazardous Substances Data: 6451-86-1(Hazardous Substances Data)

Usage

Uses

6-Bromobenzylisovanillin is an intermediate in the synthesis of 3,8-Dihydroxy-9-methoxy-6H-Dibenzo[b,d]pyran-6-one (D455545) which has been used in anti-wrinkle agents and is known as a collagen production promoter, MMP-1 production inhibitor and elastase activity inhibitor containing urolithin.

InChI:InChI=1/C15H13BrO3/c1-18-14-8-13(16)12(9-17)7-15(14)19-10-11-5-3-2-4-6-11/h2-9H,10H2,1H3

Upstream product

• 2973-59-3 2-bromoisovanillin 
• 100-44-7 benzyl chloride 
• 40705-20-2 3-benzyloxy-6-bromo-4-hydroxybenzaldehyde 
• 77-78-1 dimethyl sulfate 
• 6346-05-0 3-benzyloxy-4-methoxybenzaldehyde 
• 100-39-0 benzyl bromide 
• 5392-10-9 2-bromo-4,5-dimethoxybenzaldehyde 
• 120-14-9 3,4-dimethoxy-benzaldehyde 
• 621-59-0 isovanillin 
• 15930-53-7 6-bromo-3,4-methylenedioxybenzaldehyde 
• 100-51-6 benzyl alcohol 
• 108-95-2 phenol 
• 881-57-2 isovanillin acetate 
• 69048-79-9 4-bromo-5-formyl-2-methoxyphenyl acetate 

Downstream Products

• 105479-91-2 5-Benzyloxy-4-methoxy-2-methylsulfanyl-benzaldehyde 
• 102357-86-8 methyl 2-azido-3-(5-benzyloxy-2-bromo-4-methoxyphenyl)propenoate 
• 163595-81-1 5-benzyloxy-2-bromo-4,β-dimethoxystyrene 
• 13397-01-8 [5-(benzyloxy)-2-bromo-4-methoxyphenyl]methanol 
• 105479-94-5 5-Benzyloxy-2-benzylsulfanyl-4-methoxy-benzaldehyde 
• 221876-38-6 (5-benzyloxy-2-bromo-4-methoxyphenyl)acetaldehyde 
• 2973-59-3 2-bromoisovanillin 
• 524713-42-6 5-benzyloxy-2-bromo-4-methoxyphenol 
• 612483-08-6 2-(5-benzyloxy-2-bromo-4-methoxyphenyl)-1,3-dioxane 
• 918896-58-9 1-benzyloxy-4-bromo-2-methoxy-5-[2-nitro-(E)-1-ethenyl]benzene 
• 697803-43-3 (E)-3-benzyloxy-6-bromo-4-methoxy-β-chlorostyrene 
• 1027014-58-9 5-benzyloxy-4-hydroxy-2-(2,4,6-trimethoxy-benzylsulfanyl)-benzaldehyde 
• 796843-30-6 4-benzyloxy-5,2',3',4'-tetramethoxy-biphenyl-2-carbaldehyde 
• 796843-31-7 4-benzyloxy-5,2',4'-trimethoxy-biphenyl-2-carbaldehyde 

Relevant articles and documents

On the chloride lability in electron-rich second-generation ruthenium benzylidene complexes

A series of electron-rich second-generation cis-dichloro ruthenium aldehyde-chelating benzylidene complexes was prepared, characterized, and tested in typical ring-opening metathesis polymerization (ROMP) experiments. The benzylidene precursors were prepa

Preparation method of aporphine alkaloid

The invention discloses a preparation method of aporphine alkaloid as shown in a formula III. The method comprises the following steps: taking a benzaldehyde compound as shown in a formula III-0 as a raw material, and sequentially carrying out Wittig reaction, Pictet-Spengler reaction, Heck reaction and palladium carbon hydrogen deprotection. A bromine-containing benzaldehyde derivative is selected as a raw material, the carbon-carbon coupling co-production rate and the reaction rate are increased through bromine atoms, and the reaction activity is improved; benzyl chloroformate is adopted for NH protection, and an electron withdrawing group is introduced, so that the reaction yield can be improved; and a styrene methyl ether derivative directly reacts with an acylated phenylethylamine derivative in an acid catalysis system by adopting a one-pot method so as to obtain benzyl tetrahydroisoquinoline. The preparation method has the advantages of mild reaction conditions, low toxicity of used reagents, easily available raw materials, convenient post-treatment and simpler reaction route compared with previous reports, and can be suitable for various reaction substrates.

Fused tricyclic compounds and application thereof in medicaments

The invention relates to fused tricyclic compounds and an application thereof in medicaments, and in particular to an application of the fused tricyclic compounds in medicaments for treating and/or preventing hepatitis B. In particular, the invention rela